Montreal, Canada

Christophe Moinet

USPTO Granted Patents = 15 


Average Co-Inventor Count = 4.3

ph-index = 5

Forward Citations = 143(Granted Patents)


Location History:

  • Laval, CA (2009 - 2011)
  • Montreal, CA (2004 - 2012)
  • Quebec, CA (2012)
  • Noyal Chatillon, FR (2012 - 2013)

Company Filing History:


Years Active: 2004-2013

Loading Chart...
Loading Chart...
15 patents (USPTO):Explore Patents

Title: Innovator Spotlight: Christophe Moinet - Pioneering HIV Treatment Researcher

Introduction: Christophe Moinet, a prominent inventor based in Montreal, Canada, has made significant contributions to the field of HIV treatment with his groundbreaking patents and innovative research. With a total of 15 patents to his name, Moinet stands out as a visionary in the pharmaceutical industry.

Latest Patents: One of Moinet's latest patents includes the development of C-21-keto lupane derivatives, compounds that display remarkable anti-HIV activity. These compounds, along with their pharmaceutical salts and solvates, hold great promise for the prevention and treatment of HIV infections. Another patent focuses on lupane derivatives that show efficacy in combating HIV, showcasing Moinet's dedication to advancing the fight against this global health challenge.

Career Highlights: Throughout his career, Christophe Moinet has made significant strides in the pharmaceutical sector. He has been associated with reputable companies such as Viro Chem Pharma, Inc. and Societe De Conseils De Recherches Et D'applications Scientifiques (S.C.R.A.S.), where he has played a pivotal role in driving innovation and progress in drug development. Moinet's expertise and passion for research have earned him recognition as a leading figure in the field.

Collaborations: Moinet has collaborated with esteemed colleagues such as Laval Chan Chun Kong and Christophe Thurieau, pooling together their diverse skill sets and knowledge to push the boundaries of pharmaceutical innovation. These partnerships have been instrumental in shaping Moinet's inventive approach and fostering a collaborative spirit within the industry.

Conclusion: Christophe Moinet's exceptional work in the realm of HIV treatment research exemplifies his unwavering commitment to creating positive change through innovation. His contributions have not only advanced scientific understanding but also offered new hope in the fight against HIV. Moinet's legacy as an inventive thinker and dedicated researcher continues to inspire progress in the field of pharmaceuticals.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…